Skip to main content

Endometrial carcinoma in a gravid uterus: a case report and literature review



Endometrial carcinoma (EC) is rarely diagnosed during pregnancy. Therefore, the histopathological findings, clinical course, and gross appearance of the resected uterus during pregnancy are not well known. We present a case of EC diagnosed during pregnancy. In addition, we reviewed the literature dating from January 1995 to March 2019 for cases of EC diagnosed during pregnancy and within 15 months after pregnancy, and we discussed this topic to improve the understanding of this rare condition.

Case presentation

A 35-year-old woman underwent an urgent cesarean delivery in gestational week 35 due to antepartum bleeding caused by placenta previa. Hysterectomy was performed with the diagnosis of placenta accreta spectrum (PAS). Remarkably, the postoperative gross and histopathological examinations revealed an endometrioid adenocarcinoma (grade 1). The histopathological findings revealed a pattern similar to that of EC not related with pregnancy. Immunohistochemistry revealed an overexpression of the estrogen and progesterone receptors; however, the p53 expression was negative. We performed laparoscopic bilateral salpingo-oophorectomy and pelvic lymphadenectomy 102 days after the cesarean hysterectomy, and confirmed surgical stage IA without metastases. Our patient has had no recurrence in 4 years after the cesarean delivery.

An electronic search of the literature revealed 25 cases of EC (including our case) diagnosed during or after pregnancy. Sixteen of the 25 patients were diagnosed after abortions in the first trimester, 9 were diagnosed within 14 months of childbirth, and our case was the first with diagnosis from a surgical specimen of peripartum hysterectomy due to the PAS. In 23 of the 25 cases endometrioid adenocarcinoma grade 1 to 2 was found, and it seemed to have a good prognosis.


The present findings suggest that careful examination of a resected uterus is essential, even when surgery is performed for an obstetric indication. Our case is an extremely rare case of EC during pregnancy; the histopathological pattern was similar to that of typical EC, and no recurrence was noted. The high levels of estrogen and progesterone during pregnancy did not seem to promote tumor progression in our case.

Peer Review reports

This study presents a case of endometrioid carcinoma diagnosed during pregnancy. We performed literature review and discussed this topic. We have discussed the effects of pregnancy on endometrioid carcinoma in a previous study. Our present study found the points listed below.

  1. 1.

    Although endometrial carcinoma during pregnancy is extremely rare, careful observation of the resected uterus is needed to avoid a missed diagnosis.

  2. 2.

    In our case, histopathological and immunohistochemical findings were consistent with endometrioid adenocarcinoma grade 1. The patient has been disease-free for about 4 years after cesarean hysterectomy. The high levels of estrogen and progesterone during pregnancy did not seem to promote tumor progression in our case.

  3. 3.

    Although high levels of estrogen (which has a promoting effect on endometrioid carcinoma) and progesterone (which has an anti-tumor effect on endometrioid carcinoma) were observed, most authors reported that the endometrioid carcinoma associated with pregnancy had a good prognosis with minimal myometrial invasion.


Endometrial carcinoma (EC) is the fourth most common cancer in women in high-income countries; however, EC commonly occurs in peri- or postmenopausal women, and only 5% of women are diagnosed with adenocarcinoma before the age of 40 years [1, 2]. Therefore, the coexistence of EC and pregnancy is rare. Moreover, EC is rarely detected during pregnancy or within a year postpartum because the tumor can disrupt the pregnancy. Although a previous study had already reviewed the latest 35 reports on EC coexisting with pregnancy during the last 80 years [3], the outcome of EC associated with pregnancy and the effect of pregnancy on EC is not well known. Previous literature review also showed that there have been no reports of diagnosing EC during pregnancy in the surgical specimen of cesarean hysterectomy. Therefore, we report a case of EC diagnosed in a postoperative histopathological examination after total hysterectomy for placenta accreta spectrum (PAS), and we additionally present the results of a literature review on this matter.

Case presentation

A 35-year-old woman (gravida 2, para 1) was referred to our hospital due to placenta previa at gestational week 31. Her medical history was unremarkable, and her previous pregnancy was an uncomplicated, normal vaginal delivery at gestational week 38. Her current pregnancy was uncomplicated except for the placenta previa. She denied abnormal genital bleeding before the current pregnancy. Cervical cytology performed during early pregnancy was negative for intraepithelial lesions. Vaginal ultrasonography revealed total placenta previa and one lacuna (Fig. 1a). Magnetic resonance imaging (MRI) at gestational week 31 revealed total placenta previa and loss of the myometrium between the placenta and bladder wall (Fig. 1b). Other MRI findings of PAS such as uterine bulging, heterogenous placenta, and T2 dark band were not observed. Based on these findings, we suspected PAS, and an emergency cesarean delivery was performed owing to antepartum bleeding (approximately 100 mL) at gestational week 35. An abdominal midline incision was made, and a healthy male infant weighing 2274 g (− 0.42 SD) was delivered with Apgar scores of 8 and 9, at 1 and 5 min, respectively. The placenta was not delivered within 30 min after fetal delivery, thus requiring hysterectomy for PAS. Estimated blood loss was 1000 mL. The postoperative course was uneventful, and the patient and baby were discharged on the 8th postoperative day.

Fig. 1

Images for assessment of placenta accreta spectrum. a Transvaginal ultrasonography shows total placenta previa with one lacuna. b Magnetic resonance imaging (MRI) at gestational week 31 revealed total placenta previa, and the placenta was located mainly on the anterior side. Although intraplacental T2 dark band, uterine bulging, and heterogeneous placenta were not observed, we found myometrial thinning of the anterior wall and loss of myometrium between the placenta and bladder wall. The black arrow indicates loss of uterine myometrium between the placenta and bladder wall. Based on these findings, we suspected placenta accreta spectrum. No abnormal finding was observed in the fetus

Part of the chorion and placenta were adhered to the uterus (Fig. 2a). The resected uterus was divided to 7 specimens in order to perform macroscopic and histopathological analyses. The surgical specimen showed a white polyp measuring 2 cm, which parted from the uterine fundus and the lower uterine segment (Fig. 2b). Histopathological examination of the tumor involving the lower uterine segment revealed endometrioid adenocarcinoma (Grade 1), with < 50% myometrial invasion and positive expression of estrogen and progesterone receptors, in addition to PAS (Fig. 3a and b). Notably, the tumor involving the uterine fundus did not show myometrial invasion. Histopathological findings were similar in both tumors located in the uterine lower segment and uterine fundus. A retrospective review of the MRI images obtained during pregnancy revealed the tumor involving the uterine fundus, although involvement of the lower uterine segment was difficult to detect (Fig. 3c). We performed a laparoscopic bilateral salpingo-oophorectomy and pelvic lymphadenectomy 102 days after cesarean hysterectomy and confirmed the absence of metastases. The tumor was a stage IA lesion based on the International Federation of Gynecology and Obstetrics system. Follow-up performed 4 years after cesarean hysterectomy revealed no recurrence.

Fig. 2

Macroscopic findings in the surgical specimen. a The image shows gross findings in the uterus, which was resected due to placenta accreta spectrum. The white arrow indicates a white tumor measuring 3 cm in diameter, involving the lower uterine segment, which was diagnosed as endometrial carcinoma by histopathological analysis. The tumor involving the uterine fundus is not identifiable because it is covered by the placenta. b The image shows a longitudinal section of the uterus, which was divided into 7 sections. After the placenta was removed, a white tumor measuring 2 cm in diameter involving the uterine fundal segment was seen. The black arrow indicates the 3-cm diameter tumor which was endometrial carcinoma involving the lower uterine segment; the white arrow indicates the tumor involving the uterine fundus. Both tumors were soft and white, and the macroscopic findings were similar in both tumors

Fig. 3

Postoperative analysis of histopathological findings, magnetic resonance imaging, and immunohistochemistry staining. a The image shows the histopathological findings in the resected uterine specimen. Well-differentiated adenocarcinoma with focal cribriform pattern, back-to-back structure without intervening stroma, and a papillary area are observed, and the glands have a smooth luminal contour. The tumor shows predominant glandular growth and a < 5% nonsquamous solid component; thus, the tumor was diagnosed as endometrial cancer grade 1. The tumor at the lower uterine segment shows slight myometrial invasion. The white arrow indicates the tumor in the uterine lower segment which shows invasion of the placenta decidua and uterine myometrium. The black arrow indicates < 50% myometrial invasion (hematoxylin and eosin stain, × 40.) b Immunohistochemistry analysis showed positive expression of estrogen and progesterone receptors, and negative expression of p53. (Magnification, × 40.) c Retrospectively reviewed magnetic resonance imaging (MRI) revealed endometrial carcinoma in the uterine fundus. A sagittal T2-weighted MR image shows endometrial carcinoma measuring 3 cm in diameter with signal intensity resembling that of the placenta. The white arrow indicates endometrial carcinoma involving the uterine fundus

Discussion and conclusion

Our case demonstrated the gross and histopathological findings, MRI findings, and clinical course of EC during pregnancy. To discuss this rare condition, we performed a literature review of cases of endometrioid carcinoma associated with pregnancy. We defined EC associated with pregnancy as diagnosed at delivery to within 15 months after pregnancy. We performed a search of PubMed, MEDLINE, and Scopus databases for the period between January 1995 and March 2019, using the following key words: “endometrial cancer”, “endometrial carcinoma”, “endometrioid cancer”, “endometrioid carcinoma”, “corpus cancer”, “pregnancy”, “abortion”, and “postpartum” in various combinations. We excluded non-English articles, discontinued journal and those published before 1995. We summarized the timing of diagnosis, outcome of EC, symptoms, diagnosis of histopathological examination, surgical stage (base on FIGO 2008) [4], and surgical treatment for EC. We also listed the authors’ opinions and discussions about the effect of pregnancy on the prognosis of EC.

A total of 18 studies with 25 cases of EC associated with pregnancy (including our case) have been reported [3, 5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]; 9 cases were identified postpartum up to the 14-month; 16 cases were diagnosed at the time of D&C for first-trimester spontaneous or elective abortion. These results suggest that clinicians should consider EC after pregnancy even though abnormal bleeding is often observed after pregnancy, and EC associated with pregnancy is rare. Our literature review revealed that there were no previous reports of a diagnosis of EC based on an examination of the resected uterus following cesarean hysterectomy for PAS [3, 7]. Although our case is extremely rare, clinicians should check the macroscopic finding of the resected uterus carefully regardless of the indication for hysterectomy.

Our literature review showed that the histopathological classification was endometrioid adenocarcinoma grade 1–2 in 23 of the 25 cases, unknown grade of endometrioid adenocarcinoma in 1 of the 25 cases, and poorly differentiated adenosquamous carcinoma in 1 of the 25 cases. Immunohistochemical (IHC) analysis was performed in 9 of the 24 cases and revealed a typical staining pattern as previously reported [21, 22]. Previous reports have shown that women younger than 45 years rarely developed EC, and the most common subtype of classification in younger women was endometrioid adenocarcinoma grade 1–2 [23, 24]. Although the number was limited, these results suggested that pregnancy did not affect the subtype and IHC staining pattern of EC. We considered that our literature review might be biased because we could include only published literature and cases that made it to the scientific publication stage and this condition might be under-reported; thus, this is the limitation of our study.

The case we presented is rare, and this report highlights several interesting points, as follows: 1. It describes the histopathological analysis of EC during pregnancy; 2. It describes a tumor involving the lower uterine segment and simultaneously the uterine fundus; and 3. It describes the MRI appearance of EC during pregnancy.

Histopathological examination of the specimen revealed EC that presented as a well-differentiated adenocarcinoma with a focal cribriform pattern, back-to-back structure, and a papillary area. Although IHC analysis showed positive expression of estrogen and progesterone receptors, our patient did not demonstrate any metastases, and no recurrence was observed 4 years after the cesarean hysterectomy. These features resemble those of typical grade 1 endometrioid adenocarcinoma [25,26,27]. We concluded that the high-dose estrogen and progesterone condition during pregnancy did not promote progression of the EC. As shown in Table 1, most authors considered that pregnancy did not worsen the prognosis of EC. Further cases are expected to discuss how the pregnancy affects the prognosis of EC. Moreover, the histopathological and IHC findings in our case showed similar pattern to those of typical EC.

Table 1 A summary of the literature review findings for endometrioid carcinoma associated with pregnancy

The reason for the presentation of separate tumors at the uterine fundus and lower uterine segment is unknown. Histopathological analysis of both tumors showed similar findings; thus, we concluded that the tumor presented as 2 separate growths at the aforementioned sites owing to enlargement of the uterus during pregnancy (although this remains speculative). Other possibilities considered were metastasis or multi-site involvement of EC. Myometrial invasion was insignificant; thus, we excluded metastasis as a possible etiology. The possibility of multi-site involvement of EC is difficult to exclude; however, the estimated frequency of this condition is low. Therefore, we concluded that the tumor separation could be attributed to the uterine enlargement during pregnancy.

MRI scans were retrospectively analyzed after the cesarean hysterectomy. We observed a lesion in the uterine fundus measuring approximately 3 cm in diameter with signal intensity similar to that of the placenta. Notably, this lesion was separate from the placenta. Clinicians must consider the possibility of EC in women with MRI scans showing such lesions during pregnancy.

In conclusion, our findings in this case suggest that careful analysis of MRI findings during pregnancy and gross examination of the resected uterus (in patients undergoing hysterectomy for obstetric complications) are essential, although EC during pregnancy is extremely rare. The literature review suggested that EC associated with pregnancy seemed to have a good prognosis.

Availability of data and materials

Not applicable.



Dilatation & Curettage


Endometrial carcinoma




Magnetic resonance imaging


Placenta accreta spectrum


  1. 1.

    Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575–80.

    Article  Google Scholar 

  2. 2.

    Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, et al. Breastfeeding and endometrial Cancer risk: an analysis from the epidemiology of endometrial Cancer consortium. Obstet Gynecol. 2017;129:1059–67.

    Article  Google Scholar 

  3. 3.

    Hannuna KY, Putignani L, Silvestri E, Pisa R, Angioli R, Signore F. Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer. 2009;19:1580–4.

    Article  Google Scholar 

  4. 4.

    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.

    Article  Google Scholar 

  5. 5.

    Kovacs AG, Cserni G. Endometrial adenocarcinoma in early pregnancy. Gynecol Obstet Investig. 1996;41:70–2.

    CAS  Article  Google Scholar 

  6. 6.

    Kodama J, Yoshinouchi M, Miyagi Y, Kobashi Y, Kamimura S, Okuda H, et al. Advanced endometrial cancer detected at 7 months after childbirth. Gynecol Oncol. 1997;64:501–6.

    CAS  Article  Google Scholar 

  7. 7.

    Schammel DP, Mittal KR, Kaplan K, Deligdisch L, Tavassoli FA. Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature. Int J Gynecol Pathol. 1998;17:327–35.

    CAS  Article  Google Scholar 

  8. 8.

    Ayhan A, Gunalp S, Karaer C, Gokoz A, Oz U. Endometrial adenocarcinoma in pregnancy. Gynecol Oncol. 1999;75:298–9.

    CAS  Article  Google Scholar 

  9. 9.

    Foersterling DL, Blythe JG. Ovarian carcinoma, endometrial carcinoma, and pregnancy. Gynecol Oncol. 1999;72:425–6.

    CAS  Article  Google Scholar 

  10. 10.

    Vaccarello L, Apte SM, Copeland LJ, Boutselis JG, Rubin SC. Endometrial carcinoma associated with pregnancy: a report of three cases and review of the literature. Gynecol Oncol. 1999;74:118–22.

    CAS  Article  Google Scholar 

  11. 11.

    Mitsushita J, Toki T, Kato K, Fujii S, Konishi I. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol. 2000;79:129–32.

    CAS  Article  Google Scholar 

  12. 12.

    Ishioka S, Sagae S, Saito T, Sugimura M, Akutagawa N, Nishimura M, et al. A case of uterine endometrial carcinoma 15 months post-partum. J Obstet Gynaecol Res. 2000;26:417–20.

    CAS  Article  Google Scholar 

  13. 13.

    Ichikawa Y, Takano K, Higa S, Tanabe M, Wada A, Sugita M, et al. Endometrial carcinoma coexisting with pregnancy, presumed to derive from adenomyosis: a case report. Int J Gynecol Cancer. 2001;11:488–90.

    CAS  Article  Google Scholar 

  14. 14.

    Itoh K, Shiozawa T, Shiohara S, Ashida T, Konishi I. Endometrial carcinoma in septate uterus detected 6 months after full-term delivery: case report and review of the literature. Gynecol Oncol. 2004;93:242–7.

    Article  Google Scholar 

  15. 15.

    Terada T. Endometrial adenocarcinoma in spontaneous abortion. Pathology. 2009;41:694–5.

    Article  Google Scholar 

  16. 16.

    Akil A, Kaya B, Karabay A, Kibar Y. Concurrent endometrial adenocarcinoma and an early pregnancy loss. Arch Gynecol Obstet. 2012;286:1089–90.

    Article  Google Scholar 

  17. 17.

    Saciragic L, Ball CG, Islam S, Fung-Kee-Fung M. Incidental endometrial carcinoma diagnosed at first trimester pregnancy loss: a case report. J Obstet Gynaecol Can. 2014;36:1010–3.

    Article  Google Scholar 

  18. 18.

    Bayoglu Tekin Y, Guvendag Guven ES, Sehitoglu I, Guven S. Tubal pregnancy associated with endometrial carcinoma after in vitro fertilization attempts. Case Rep Obstet Gynecol. 2014;2014:481380.

    PubMed  PubMed Central  Google Scholar 

  19. 19.

    Zhou F, Qian Z, Li Y, Qin J, Huang L. Endometrial adenocarcinoma in spontaneous abortion: two cases and review of the literature. Int J Clin Exp Med. 2015;8:8230–3.

    PubMed  PubMed Central  Google Scholar 

  20. 20.

    Rizzuto I, Nicholson R, Dickinson K, Juang HJ, MacNab W, Rufford B. A case of incidental endometrial adenocarcinoma diagnosed in early pregnancy and managed conservatively. Gynecol Oncol Rep. 2019;28:101–3.

    CAS  Article  Google Scholar 

  21. 21.

    Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73.

    Article  Google Scholar 

  22. 22.

    Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15:e268–78.

    Article  Google Scholar 

  23. 23.

    Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200:678 e1–6.

    Article  Google Scholar 

  24. 24.

    Committee on Practice B-G. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120:197–206.

    Article  Google Scholar 

  25. 25.

    Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, et al. Ovarian conservation and overall survival in young women with early-stage low-grade endometrial Cancer. Obstet Gynecol. 2016;128:761–70.

    Article  Google Scholar 

  26. 26.

    Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008;111(2 Pt 1):436–47.

    Article  Google Scholar 

  27. 27.

    Guan J, Xie L, Luo X, Yang B, Zhang H, Zhu Q, et al. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. J Gynecol Oncol. 2019;30:e13.

    Article  Google Scholar 

Download references


The authors thank H. Abe and K. Sakiyama for administrative assistance in the preparation of this manuscript.


There is no source of financial support or funding.

Author information




MS, SM, EK, and YU made substantial contributions to conception and design, collected the clinical data and drafted as well as revised the manuscript. EK, TH, SN, TTa, TTo, and KM helped in reviewing the previous studies and drafting the manuscript. TK conceived and generally supervised of this study, and gave final approval of the version to be published. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shinya Matsuzaki.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Review Board and the Ethics Committee of the Osaka University Hospital (approval #15240, approved on September 10, 2015).

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

Shinya Matsuzaki is an Associate Editor for BMC Pregnancy and Childbirth. The authors declare no conflicts of interest about this study. All of authors have no competing financial interests regarding this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shiomi, M., Matsuzaki, S., Kobayashi, E. et al. Endometrial carcinoma in a gravid uterus: a case report and literature review. BMC Pregnancy Childbirth 19, 425 (2019).

Download citation


  • Placenta accreta spectrum
  • Placenta previa
  • Pregnancy
  • Endometrioid carcinoma endometrial carcinoma
  • Endometrial cancer